[go: up one dir, main page]

PE20001021A1 - Combinacion de un anti ep-cam con un agente quimioterapico - Google Patents

Combinacion de un anti ep-cam con un agente quimioterapico

Info

Publication number
PE20001021A1
PE20001021A1 PE1999000745A PE00074599A PE20001021A1 PE 20001021 A1 PE20001021 A1 PE 20001021A1 PE 1999000745 A PE1999000745 A PE 1999000745A PE 00074599 A PE00074599 A PE 00074599A PE 20001021 A1 PE20001021 A1 PE 20001021A1
Authority
PE
Peru
Prior art keywords
cam
antigen
cells
antibody
combination
Prior art date
Application number
PE1999000745A
Other languages
English (en)
Spanish (es)
Inventor
Vincent C Knick
Julie Beth Stimmel
Linda M Thurmond
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20001021A1 publication Critical patent/PE20001021A1/es

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE1999000745A 1998-07-27 1999-07-26 Combinacion de un anti ep-cam con un agente quimioterapico PE20001021A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9816280.3A GB9816280D0 (en) 1998-07-27 1998-07-27 Antibody combination

Publications (1)

Publication Number Publication Date
PE20001021A1 true PE20001021A1 (es) 2000-10-10

Family

ID=10836207

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000745A PE20001021A1 (es) 1998-07-27 1999-07-26 Combinacion de un anti ep-cam con un agente quimioterapico

Country Status (5)

Country Link
AR (1) AR020631A1 (fr)
CO (1) CO5090883A1 (fr)
GB (1) GB9816280D0 (fr)
MA (1) MA26665A1 (fr)
PE (1) PE20001021A1 (fr)

Also Published As

Publication number Publication date
GB9816280D0 (en) 1998-09-23
MA26665A1 (fr) 2004-12-20
AR020631A1 (es) 2002-05-22
CO5090883A1 (es) 2001-10-30

Similar Documents

Publication Publication Date Title
MX9306924A (es) Composiciones antitumorales que contienen derivados de taxano.
PA8479201A1 (es) Derivados del acido hidroxi-pipecolato hidroxamico
HUP0300590A2 (hu) Peptidázzal hasítható, célzott antineoplasztikus szerek és terápiás alkalmazásuk
AR049305A1 (es) Método para tratar cancer resistente al platino con un anticuerpo her2 y un agente quimioterapéutico:gemcitabina
PE20091328A1 (es) Formulacion de anticuerpo
AR042051A1 (es) Tratamiento combinado contra el cancer con un compuesto anti-cancerigeno activado por glutationa s- transferasa (gst) y otro tratamiento contra el cancer
HK1175846A1 (en) Cytotoxicity mediation of cells evidencing surface expression of cd44 cd44
ATE444309T1 (de) Immuntherapie für kronische myelozytische leukämie mit nacktem anti-nca-90 antikörper
BR0213424A (pt) Uso aperfeiçoado de composto antitumoral na terapia contra câncer
AR031250A1 (es) Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon
MX2017000610A (es) Metodos combinados para tratar canceres.
CO2022015428A2 (es) Compuesto de oxofenilarsina deuterada y uso del mismo
ATE290388T1 (de) Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c
ATE269700T1 (de) Verwendung von docetaxel für die behandlung von hepatozelluläre krebs
AR030699A1 (es) Compuesto ligando de integrina, uso del elemento estrutural-g-l para prepararlo, droga que contiene a este ultimo, preparacion farmaceutica que comprende a dicho compuesto y uso para la produccion de drogas.
PE20001021A1 (es) Combinacion de un anti ep-cam con un agente quimioterapico
ATE241376T1 (de) Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten
KR960700734A (ko) 사람 암에 대한 시스플래틴/타목시펜 배합 치료(Combination cisplatin/tamoxifen therapy for human cancers)
CY1111813T1 (el) Αντικαρκινικο εμβολιο που περιλαμβανει αλλογονιδιακα ή ξενογονιδιακα καρκινικα κυτταρα
AR023726A1 (es) Terapia con gch para el tratamiento del cancer de mama
BE899987A (fr) Nouvelles compositions pharmaceutiques antitumorales.
Crane et al. A Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: RTOG PA0411
SU547496A1 (ru) Тиксотромный раствор
ZA202405344B (en) Use of a class of 1,4-dihydro-naphthyridine derivatives in treatment of tumors
FR2059478A1 (en) Anticarcinogenic compns contng vitamin a - acids

Legal Events

Date Code Title Description
FC Refusal